• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
Gynesonics

Gynesonics

Advancing technology. Improving women's lives.

  • Our Company
    • About Us
    • Careers
    • Compliance and Quality
  • Our People
    • Management
    • Board of Directors
    • Investors
  • Our Technology
    • The Sonata System
    • Indications and Safety
    • Instructions for Use
    • Request for Medical or Scientific Information
  • Our News
    • Press Releases
    • In the News
    • Publications
  • Contact Us

tmurphy

Gynesonics Announces Publication of CHOICES: A Comparative Study of the Sonata Treatment Versus Myomectomy

June 30, 2020

Sonata Demonstrates Significant Advantages in Reducing Procedure Time, Length of Stay and Procedure Related Costs Compared to Myomectomy Redwood City, CA, June 30, 2020 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine

Sonata System Assists Facilities Impacted by the COVID-19 Pandemic in Restarting Elective Gynecologic Procedures

June 22, 2020

Positive Aspects of Transcervical Fibroid Ablation, Strong Clinical Results, Provides Facilities with Confidence in Treating Fibroids and Minimizing Potential Viral Risks – Procedural Volumes Increasing Redwood City, CA – June 22, 2020 - Gynesonics®, a women’s healthcare company focused on the

  • « Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4

Primary Sidebar

  • Privacy Notice
  • Cookie Notice
  • Terms of Use
  • Impressum
  • Patents
  • Safety Information

© Copyright 2025 Gynesonics · All Rights Reserved · WS 05198 Rev. L

  • Privacy Notice
  • Cookie Notice
  • Terms of Use
  • Impressum
  • Patents
  • Safety Information